Establishment Labs Holdings (ESTA) Exchange Rate Effect (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Exchange Rate Effect came in at -$337000.0 in Q1 2026, down 130.78% year-on-year from $1.1 million in Q1 2025, and down 147.0% quarter-over-quarter from $717000.0 in Q4 2025.
Establishment Labs Holdings (ESTA) Exchange Rate Effect (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Exchange Rate Effect history runs 10 years deep, the most recent figure standing at -$337000.0 for Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 130.78% year-over-year to -$337000.0 in Q1 2026; TTM through Mar 2026 was $1.3 million, a 3214.63% increase from a year earlier, with the FY2025 full-year figure at $2.7 million, up 286.06% from the prior year.
- Exchange Rate Effect eased to -$337000.0 in Q1 2026 per ESTA's latest filing, from $717000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.2 million in Q2 2025 and bottomed at -$1.3 million in Q4 2024.
- The 5-year median for Exchange Rate Effect is $125000.0 (2022), against an average of $63000.0.
- Across the five-year window, Exchange Rate Effect slumped 415.47% in 2022 and surged 640.19% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at $473000.0 in 2022, then climbed by 15.86% to $548000.0 in 2023, then slumped by 332.3% to -$1.3 million in 2024, then surged by 156.32% to $717000.0 in 2025, then sank by 147.0% to -$337000.0 in 2026.
- Per Business Quant, the three latest ESTA Exchange Rate Effect figures stand at -$337000.0 (Q1 2026), $717000.0 (Q4 2025), and -$259000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -23.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -19.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 33.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 8.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -2.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.66 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -37.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | -337,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -337,000.00 |
| Mar 31, 2026 | -337,000.00 |
| Dec 31, 2025 | 717,000.00 |
| Dec 31, 2025 | 717,000.00 |
| Sep 30, 2025 | -259,000.00 |
| Sep 30, 2025 | -259,000.00 |
| Jun 30, 2025 | 1.16 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | -1.27 Mn |
| Dec 31, 2024 | -1.27 Mn |
| Sep 30, 2024 | 351,000.00 |
| Sep 30, 2024 | 351,000.00 |
| Jun 30, 2024 | -214,000.00 |
| Jun 30, 2024 | -214,000.00 |
| Mar 31, 2024 | -320,000.00 |
| Mar 31, 2024 | -320,000.00 |
| Dec 31, 2023 | 548,000.00 |
| Dec 31, 2023 | 548,000.00 |